CINECA IRIS Institutional Research Information System

VOLANTE, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.092
EU - Europa 10.587
AS - Asia 7.172
SA - Sud America 637
OC - Oceania 237
AF - Africa 189
Continente sconosciuto - Info sul continente non disponibili 23
Totale 35.937
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.647
CN - Cina 3.141
IT - Italia 2.647
DE - Germania 1.100
SG - Singapore 1.076
IE - Irlanda 979
FR - Francia 953
SE - Svezia 817
JP - Giappone 632
UA - Ucraina 605
FI - Finlandia 554
GB - Regno Unito 533
IN - India 509
KR - Corea 503
PL - Polonia 387
BR - Brasile 372
AT - Austria 347
ES - Italia 334
CA - Canada 323
VN - Vietnam 315
TR - Turchia 266
AU - Australia 211
NL - Olanda 211
ID - Indonesia 152
GR - Grecia 144
RU - Federazione Russa 144
DK - Danimarca 139
BE - Belgio 124
AR - Argentina 118
HK - Hong Kong 116
MX - Messico 105
CH - Svizzera 98
TW - Taiwan 95
SN - Senegal 88
PT - Portogallo 87
HU - Ungheria 81
RO - Romania 79
TH - Thailandia 61
CL - Cile 55
IL - Israele 55
CZ - Repubblica Ceca 53
CO - Colombia 50
SA - Arabia Saudita 50
MY - Malesia 43
NO - Norvegia 37
PH - Filippine 35
DZ - Algeria 30
HR - Croazia 26
RS - Serbia 26
UZ - Uzbekistan 25
NZ - Nuova Zelanda 24
PK - Pakistan 23
SI - Slovenia 23
EU - Europa 22
EG - Egitto 18
EC - Ecuador 17
PE - Perù 15
ZA - Sudafrica 14
IR - Iran 11
SK - Slovacchia (Repubblica Slovacca) 11
AE - Emirati Arabi Uniti 10
BG - Bulgaria 9
BA - Bosnia-Erzegovina 8
BY - Bielorussia 8
JO - Giordania 8
LT - Lituania 8
AM - Armenia 7
QA - Qatar 7
IQ - Iraq 6
MA - Marocco 6
NG - Nigeria 6
SD - Sudan 6
VE - Venezuela 6
MK - Macedonia 5
PR - Porto Rico 5
BD - Bangladesh 4
TN - Tunisia 4
UY - Uruguay 4
KE - Kenya 3
KZ - Kazakistan 3
MO - Macao, regione amministrativa speciale della Cina 3
MT - Malta 3
MU - Mauritius 3
OM - Oman 3
PA - Panama 3
SC - Seychelles 3
SY - Repubblica araba siriana 3
CU - Cuba 2
CY - Cipro 2
EE - Estonia 2
FJ - Figi 2
GT - Guatemala 2
LB - Libano 2
RE - Reunion 2
TG - Togo 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AZ - Azerbaigian 1
BS - Bahamas 1
DO - Repubblica Dominicana 1
Totale 35.921
Salva come PNG Salva come JPEG
Città #
Chandler 1.558
Beijing 1.441
Houston 1.136
Fairfield 1.101
Dublin 960
Singapore 824
Ashburn 770
Ann Arbor 705
Redwood City 659
Torino 578
Wilmington 574
Woodbridge 568
Seattle 485
Santa Clara 417
Villeurbanne 399
Jacksonville 376
Cambridge 368
Nyköping 335
Pisa 334
Vienna 319
Medford 300
Princeton 300
Dearborn 289
Columbus 283
Warsaw 270
Guangzhou 176
Shanghai 174
Dong Ket 173
Milan 169
Turin 164
Boston 159
Tokyo 155
New York 145
Fremont 136
Jakarta 136
Nanjing 131
Boardman 100
Hangzhou 100
Munich 99
Würzburg 92
San Diego 85
Chicago 81
Pune 80
Chengdu 75
Seoul 74
Rome 70
Helsinki 69
São Paulo 69
Toronto 69
Los Angeles 62
Paris 62
Madrid 60
Brussels 57
Athens 56
Taipei 56
Buenos Aires 55
Norwalk 54
Shenyang 54
Düsseldorf 53
Verona 52
London 50
Bologna 49
Istanbul 49
Santiago 48
Hefei 47
Phoenix 47
Zhengzhou 47
Washington 46
Falls Church 45
Wuhan 45
Budapest 43
Padova 43
Ankara 42
New Delhi 42
Birmingham 41
Silver Spring 41
Pittsburgh 40
Brescia 39
Florence 39
Bethesda 36
Canberra 36
Rochester 36
Jinan 35
Kunming 35
Amsterdam 33
Mountain View 33
Barcelona 32
Hong Kong 32
Moscow 32
Tappahannock 32
Changsha 31
Berlin 30
Central District 30
Lexington 28
Philadelphia 28
Dallas 26
Hebei 26
Brisbane 25
Delhi 25
Piemonte 25
Totale 20.240
Salva come PNG Salva come JPEG
Nome #
The weiss score and beyond--histopathology for adrenocortical carcinoma. 1.385
The Reticulin Algorithm for Adrenocortical Tumor Diagnosis: A Multicentric Validation Study on 245 Unpublished Cases. 1.107
Cytological features of "noninvasive follicular thyroid neoplasm with papillary-like nuclear features" and their correlation with tumor histology 879
Validation of the prognostic role of the "Helsinki Score" in 225 cases of adrenocortical carcinoma 695
Adrenocortical tumors with myxoid features: a distinct morphologic and phenotypical variant exhibiting malignant behavior. 671
Mixed Adenoneuroendocrine Carcinomas (MANECs) of the Gastrointestinal Tract: Targeted Next Generation Sequencing Suggests a Monoclonal Origin of the Two Components 577
β1 integrin controls EGFR signaling and tumorigenic properties of lung cancer cells. 524
Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study. 502
IMPACT OF PREGNANCY ON PROGNOSIS OF DIFFERENTIATED THYROID CANCER: CLINICAL AND MOLECULAR FEATURES. 454
Oncocytic Adrenocortical Tumors: Diagnostic Algorithm and Mitochondrial DNA Profile in 27 Cases. 439
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane. 426
Long-Term Outcomes of Adjuvant Mitotane Therapy in Patients With Radically Resected Adrenocortical Carcinoma. 423
Tumor staging but not grading is associated with adverse clinical outcome in neuroendocrine tumors of the appendix: a retrospective clinical pathologic analysis of 138 cases. 417
Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart 404
Obestatin regulates adipocyte function and protects against diet-induced insulin resistance and inflammation. 388
Extrapulmonary neuroendocrine small and large cell carcinomas: a review of controversial diagnostic and therapeutic issues. 382
Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm 343
RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact 340
Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones 332
Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification. 330
microRNA expression patterns in adrenocortical carcinoma variants and clinical pathologic correlations 321
Functional Role and Prognostic Significance of CD157 in Ovarian Carcinoma 319
Prognostic Role of Overt Hypercortisolism in Completely Operated Patients with Adrenocortical Cancer 319
MITOTANE LEVELS PREDICT THE OUTCOME OF PATIENTS WITH ADRENOCORTICAL CARCINOMA TREATED ADJUVANTLY FOLLOWING RADICAL RESECTION. 316
An international Ki67 reproducibility study in adrenal cortical Carcinoma 301
Therapeutic Biomarkers in Lung Neuroendocrine Neoplasia 298
An exploration of pathways involved in lung carcinoid progression using gene expression profiling 297
Thymidylate synthase is functionally associated with ZEB1 and contributes to the epithelial-to-mesenchymal transition of cancer cells 295
Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence. 284
Pathology of the Adrenal Cortex: a Reappraisal of the Past 25 Years Focusing on Adrenal Cortical Tumors. 280
Poorly differentiated thyroid carcinoma: 5 years after the 2004 WHO classification of endocrine tumours. 278
Diagnostic and prognostic role of steroidogenic factor 1 in adrenocortical carcinoma: a validation study focusing on clinical and pathologic correlates 277
Sarcomatoid adrenocortical carcinoma: a comprehensive pathological, immunohistochemical, and targeted next-generation sequencing analysis 277
Targeted next-generation sequencing of cancer genes in advanced stage malignant pleural mesothelioma: a retrospective study. 266
Expression of cortistatin and MrgX2, a specific cortistatin receptor, in human neuroendocrine tissues and related tumours 261
Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma 258
RRM1 modulates mitotane activity in adrenal cancer cells interfering with its metabolization 252
Somatostatin receptor tissue distribution in lung neuroendocrine tumours: a clinicopathologic and immunohistochemical study of 218 'clinically aggressive' cases. 252
Mammalian target of rapamycin pathway activation is associated to RET mutation status in medullary thyroid carcinoma. 242
Differential expression of HER2, STAT3, SOX2, IFI16 and cell cycle markers during HPV-related head and neck carcinogenesis 241
MEN1 Gene Mutation and Reduced Expression Are Associated with Poor Prognosis in Pulmonary Carcinoids 238
Cytotoxic activity of gemcitabine, alone or in combination with mitotane, in adrenocortical carcinoma cell lines. 236
Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma 231
Retrospective multicenter study investigating the role of targeted next-generation sequencing of selected cancer genes in mucinous adenocarcinoma of the lung 226
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer 213
YAP-Dependent AXL Overexpression Mediates Resistance to EGFR Inhibitors in NSCLC 213
Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors 211
mTORC1 Complex is Significantly Over-Activated in SDHX-Mutated Paragangliomas 201
Unusual paraneoplastic neurological syndrome secondary to a well differentiated pancreatic neuroendocrine tumor: A case report and review of the literature 199
Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma 195
H-RAS mutations are restricted to sporadic pheochromocytomas lacking specific clinical or pathological features data from a multi-institutional series 193
Brca1-Associated Protein 1 (BAP1) Immunohistochemical Expression as a Diagnostic Tool in Malignant Pleural Mesothelioma Classification: a Large Retrospective Study 191
Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies 191
Mammalian target of rapamycin signaling activation patterns in neuroendocrine tumors of the lung. 189
CD157 enhances malignant pleural mesothelioma aggressiveness and predicts poor clinical outcome. 185
Detection and characterization of classical and "uncommon" exon 19 Epidermal Growth Factor Receptor mutations in lung cancer by pyrosequencing 179
Expression of SOAT1 in Adrenocortical Carcinoma and Response to Mitotane Monotherapy: An ENSAT Multicenter Study 176
Effects of Src kinase inhibition induced by dasatinib in non-small cell lung cancer cell lines treated with cisplatin 170
Retrospective study testing next generation sequencing of selected cancer-associated genes in resected prostate cancer 170
Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the xelbevoct study. 168
Increased neuroendocrine cells in resected metastases compared to primary colorectal adenocarcinomas. 166
Bevacizumab Plus Octreotide and Metronomic Capecitabine in Patients with Metastatic Well-to-Moderately Differentiated Neuroendocrine Tumors. The XELBEVOCT Multicenter Phase II Study 163
Retrospective evaluation of the outcome of open versus laparoscopic adrenalectomy for stage I and II adrenocortical cancer. 156
Inhibition of human respiratory syncytial virus infectivity by a dendrimeric heparan sulfate-binding peptide. 147
SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: A multicenter interobserver variation analysis using virtual microscopy: A Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T) 146
RFamide peptides 43RFa and 26RFa both promote survival of pancreatic β-cells and human pancreatic islets but exert opposite effects on insulin secretion. 139
Biological role and clinical significance of CD157 in epithelial ovarian cancer 138
Mechanical phenotyping of cells and extracellular matrix as grade and stage markers of lung tumor tissues 137
Highly Sulfated K5 Escherichia coli Polysaccharide Derivatives Inhibit Respiratory Syncytial Virus Infectivity in Cell Lines and Human Tracheal-Bronchial Histocultures 131
Biological role, clinical significance and potential therapeutic applications of CD157 in ovarian cancer 128
CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer 128
Tissue arrays as fiducial markers for section alignment in 3-D reconstruction technology 128
PAX8–GLIS3 gene fusion is a pathognomonic genetic alteration of hyalinizing trabecular tumors of the thyroid 128
Ribonucleotide Reductase Large Subunit (RRM1) Gene Expression May Predict Efficacy of Adjuvant Mitotane in Adrenocortical Cancer. 126
CYP2W1 Is Highly Expressed in Adrenal Glands and Is Positively Associated with the Response to Mitotane in Adrenocortical Carcinoma 125
INHIBITION OF USP7 INDUCES SELECTIVE CANCER CELL DEATH IN CHRONIC LYMPHOCYTIC LEUKEMIA THROUGH PTEN AND INDEPENDENTLY FROM P53 STATUS 125
Thymidylate synthase expression in large cell carcinoma ofthe lung 124
Clinical and biological significance of CD157 in malignant pleural mesothelioma 122
CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cells 122
Caveolin-1 expression in lung carcinoma varies according to tumour histotype and is acquired de novo in brain metastases 117
Soluble CD157 in pleural effusions: a complementary tool for the diagnosis of malignant mesothelioma 115
Differential Thymidylate Synthase Expression in Different Variants of Large-Cell Carcinoma of the Lung 115
Epidermal Growth Factor Receptor Gene in Primary Tumor and Metastatic Sites from Non-small Cell Lung Cancer. J Thorac Oncol. 2009 Apr 29 114
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 114
CD157: A New Prognostic and/or Predictive Marker in Ovarian Cancer? A Retrospective Study 113
Extensive DNA fragmentation in oxyphilic cell lesions of the thyroid. 112
Anti-CD38 autoantibodies: characterisation in new-onset type I diabetes and latent autoimmune diabetes of the adult (LADA) and comparison with other islet autoantibodies. 112
Updates on lung neuroendocrine neoplasm classification 111
Adjuvant mitotane treatment: a prospective experience at the San luigi Hospital, University of Turin, Italy, USA, 2008 111
ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine 111
CD157 is a novel prognostic marker of malignant pleural mesothelioma involved in the control of tumor aggressiveness 110
IκBα targeting promotes oxidative stress-dependent cell death 110
Integrative analysis of SF-1 transcription factor dosage impact on genome-wide binding and gene expression regulation 109
Cytology of Primary Salivary Gland-Type Tumors of the Lower Respiratory Tract: Report of 15 Cases and Review of the Literature 108
Absence of gene mutations in a case of concomitant presence of carcinoid of the ampulla of vater pheochromocytoma and Von Recklinghausen disease 107
99mTc-MIBI Imaging in the presurgical characterization of thyroid follicular neoplasms: relationship to multidrug resistance protein expression 107
Desmocollin-3: a new marker of squamous differentiation in undifferentiated large-cell carcinoma of the lung 106
Valutazione prospettica di pazienti operati radicalmente per carcinoma corticosurrenalico in trattamento con mitotane adiuvante: correlazioni tra indici di massa corporea, livelli di mitotanemia ed efficacia. 105
CD157 CONTROLS PERITONEAL DISSEMINATION AND INVASION OF OVARIAN CARCINOMA AND IS A MOLECULAR PREDICTOR OF POOR CLINICAL OUTCOME 105
Obestatin promotes glut-4 translocation and glucose uptake in 3T3-L1 adipocytes and inhibits lipolysis in 3T3-L1 and human visceral and subcutaneous adipocytes 104
Totale 25.522
Salva come PNG Salva come JPEG
Categoria #
all - tutte 92.881
article - articoli 0
book - libri 0
conference - conferenze 7.749
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.630
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.193 0 0 0 0 490 924 662 492 550 471 330 274
2020/20214.488 366 266 392 259 377 395 445 256 400 409 378 545
2021/20224.330 262 297 252 373 268 237 302 297 190 303 801 748
2022/20235.483 550 449 176 511 475 1.233 403 369 577 186 288 266
2023/20243.279 366 453 227 208 258 428 162 236 35 201 294 411
2024/20252.833 164 554 339 643 1.133 0 0 0 0 0 0 0
Totale 37.036